| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Lettmann Jason | CHIEF EXECUTIVE OFFICER, Director | C/O ALX ONCOLOGY HOLDINGS INC., 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO | /s/ Shelly Pinto, by power of attorney | 28 Jan 2026 | 0001688269 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALXO | Stock option (right to buy) | Award | $0 | +912,000 | $0.000000 | 912,000 | 26 Jan 2026 | Common Stock | 912,000 | $1.48 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Shares subject to the option vest in 48 equal monthly installments beginning on February 26, 2026. |